Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Natural killer (NK) cells can be incubated with ‘feeder cells’ expressing certain cytokines prior to maturation to enhance their activity. In particular, incubation with IL-15 allows NK cells to lyse... In particular, incubation with IL-15 allows NK cells to lyse a broad range of fresh and cultured tumor targets that the cell is not normally sensitive to.
- Mechanism
- Curator reviewed
IL-15 is a key cytokine in NK cell development and function; the IL-15 receptor (IL-15R) is constitutively expressed in both the CD56bright and CD56dim matured NK cells. Activation of the IL-15R involves 3 downstream pathways: JAK1/3/STAT3/5, P13K/Akt/mTOR, and Ras/Raf/MEK/ERK. It was shown that ‘priming’ NK-cells with IL-15 markedly enhanced anti-tumor responses which included cytotoxicity, degranulation, and cytokine production.
- Also known as
- IL15-Natural Killer Cell
- Code names
- IL15-NK cells
Resolves to
What you can answer from here — as of July 08, 2026
Which drugs share a target with IL15-NK Cell, and which of those have an active Phase 3 trial?